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Abstract: Although carbon nanomaterials (CNMs) have been increasingly studied for their 
  biomedical applications, there is limited research on these novel materials for oral drug 
  delivery. As such, this study aimed to explore the potential of CNMs in oral drug delivery, and 
the objectives were to evaluate CNM cytotoxicity and their abilities to modulate paracellular 
transport and the P-glycoprotein (P-gp) efflux pump. Three types of functionalized CNMs 
were studied, including polyhydroxy small-gap fullerenes (OH-fullerenes), carboxylic acid 
functionalized single-walled carbon nanotubes (f SWCNT-COOH) and poly(ethylene glycol) 
functionalized single-walled carbon nanotubes (f SWCNT-PEG), using the well-established 
Caco-2 cell monolayer to represent the intestinal epithelium. All three CNMs had minimum 
cytotoxicity on Caco-2 cells, as demonstrated through lactose dehydrogenase release and 
3-(4,5-dimethyliazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Of the three CNMs, 
f SWCNT-COOH significantly reduced transepithelial electrical resistance and enhanced trans-
port of Lucifer Yellow across the Caco-2 monolayer. Confocal fluorescence microscopy showed 
that f SWCNT-COOH treated cells had the highest perturbation in the distribution of ZO-1, a 
protein marker of tight junction, suggesting that f SWCNT-COOH could enhance paracellular 
permeability via disruption of tight junctions. This modulating effect of f SWCNT-COOH can 
be reversed over time. Furthermore, cellular accumulation of the P-gp substrate, rhodamine-123, 
was significantly increased in cells treated with f SWCNT-COOH, suggestive of P-gp inhibition. 
Of note, f SWCNT-PEG could increase rhodamine-123 accumulation without modifying the 
tight junction. Collectively, these results suggest that the functionalized CNMs could be useful 
as modulators for oral drug delivery, and the differential effects on the intestinal epithelium 
imparted by different types of CNMs would create unique opportunities for drug-specific oral 
delivery applications.
Keywords: fullerenes, carbon nanotubes, functionalization, paracellular transport, 
P-glycoprotein
Introduction
Carbon-based nanomaterials (CNMs) have rapidly emerged as important components 
in a wide variety of applications such as electronics, computer, aerospace, architecture, 
and potentially medicine in drug delivery and prosthetics.1–4 Owing to their unique 
electrical, mechanical, and thermal properties,2 CNMs have attracted intense academic 
and industrial interest ever since their first description.5,6 The most commonly inves-
tigated CNMs include fullerenes, single-walled and multi-walled carbon nanotubes. 
Recently, graphene and its derivatives have emerged as yet another type of CNM of 
immense interest in biomedical applications such as drug delivery.7–9 However, before 
the potential for biomedical application can be realized, the toxicity profiles of CNMs 
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must be characterized to the satisfaction of regulatory   bodies 
so that CNMs can be incorporated as safe components in 
medicinal products.
Most of the toxicological data have been obtained using 
in vitro human cell models such as dermal fibroblasts,10 
  bronchial epithelial cells,11 macrophages,12 and embryonic 
kidney (HEK293) cells.13 Animal models have also been used 
to elucidate the potential toxicity of CNMs, with rodents 
being the most commonly used. From these studies, the toxic-
ity of CNMs can be linked to a number of factors including 
metal catalyst contamination, particle size or length, surface 
area and functionalization, and aggregation state as well as 
route of exposure.1,3,14,15 Route of exposure or administration 
is an important factor in governing the type of toxicity that 
is ultimately manifested in the exposed animal or human. 
Studies investigating this factor would shed light on the 
potential of CNMs for biomedical applications such as drug 
delivery systems. Various routes of administration have been 
explored with CNMs including intravenous, intraperitoneal, 
oral, and intrascrotal. Most data have been collected on the 
intraperitoneal route and have demonstrated granuloma for-
mation resulting from carbon nanotube exposure.16–18 While 
the intraperitoneal route is commonly used in rodents because 
of ease of administration, its use in humans is mostly limited 
to peritoneal dialysis and administration of chemotherapy 
for diseases of the peritoneal cavity. Because CNMs are 
water-insoluble, dosing animals intravenously might give 
rise to mechanical blockage of blood vessels,16 thus limiting 
the potential of CNMs as delivery vehicles for intravenous 
application that necessitates appropriate functionalization 
to improve biocompatibility.14,15 Considering marketed 
drug products, oral delivery is the most common and most 
desirable route of administration. Despite the limited and 
fragmentary toxicological information gathered from oral 
CNM exposure, a few recent studies have shown that these 
nanomaterials when given orally do not give rise to the toxic 
symptoms produced by intraperitoneal exposure.16,19–21 These 
positive studies have prompted us to investigate the potential 
of CNMs as oral drug delivery vehicles.
In particular, we have explored the interactions of 
three functionalized CNMs, including: polyhydroxylated 
fullerenes (OH-fullerenes); single-walled carbon nanotubes 
functionalized with carboxylic acid (f SWCNT-COOH); and 
single-walled carbon nanotubes functionalized with polyeth-
ylene glycol (f SWCNT-PEG), with Caco-2 cell monolayer. 
These functionalized materials were selected based on their 
improved dispersibility in aqueous media, which could lend 
better biocompatibility.1,14,15,22 They have also been intensively 
studied, thus allowing comparison to existing   literature. The 
Caco-2 cell monolayer has been well established as an 
in vitro model for the study of oral drug absorption.23 The 
differentiated cell monolayer has tight junctions and drug 
efflux transporters and thus resembles the normal intestinal 
epithelium as a drug absorption barrier.24,25 A desirable oral 
drug delivery system should have the ability to modulate the 
intestinal absorptive barrier so as to transport drugs across 
and promote absorption, in addition to being minimally toxic 
to the intestinal barrier. The current study is the first to report 
on the ability of functionalized CNMs to modulate drug 
transport across the Caco-2 intestinal epithelium.
Materials and methods
Materials
The CNMs used in this study were all purchased from Sigma-
Aldrich Inc (Singapore), including the hydrated, polyhydroxy 
small gap fullerenes (C120O30(OH)30 · 30H2O · 25Na+, cat # 
707481), the f SWCNT-COOH nanotubes (with extent of 
labeling of 2.0 atom% carboxylic groups, cat # 652490), and 
the f SWCNT-PEG nanotubes (with PEG600:SWCNT weight 
ratio of 20:80, cat # 652474). Both SWCNT were produced 
by electric arc discharge method as described by the   supplier. 
Caco-2 cell line was purchased from the American Type 
Culture Collection (Manassas, VA), while the cell culture 
media and supplements were purchased from MP Biomedi-
cals (Illkirch, France).
Dispersion of CNMs in aqueous media
The three CNMs were used as received without further puri-
fication steps. The CNMs were dispersed in Hanks’s balanced 
salt solution (HBSS) containing 10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) by sonication for 
1 hour using a Branson 2510 bath sonicator (Danbury, CT) 
to produce a fine suspension at a concentration of 1 mg/mL 
for subsequent experimentation.
Characterization of CNMs
Scanning electron microscopy (SEM) of the powder form 
of the three CNMs was performed with a JEOL JSM-6701F 
(JEOL, Tokyo, Japan) field emission scanning electron 
microscope. Transmission electron microscopy (TEM) of 
the aqueous-dispersed CNMs was performed with a JEOL 
JEM-2010F field emission transmission electron microscope 
(JEOL, Tokyo, Japan). Metal content (Co, Ni, and Fe) was 
determined by inductively coupled plasma optical emission International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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spectrometry (ICP-OES) analysis with Dual-view Optima 
5300 DV ICP-OES system (Perkin Elmer Inc, Shelton, CT).
Cell culture
The Caco-2 cell line was used within 20 passages from 
thawing. Cells were grown in a humidified atmosphere of 
5% CO2 at 37°C and maintained in Eagle’s minimal essen-
tial medium (EMEM) supplemented with 20% fetal bovine 
serum (FBS), 1% L-glutamine, 100 units/mL penicillin, 
and 100 µg/mL streptomycin. Stock cultures were grown 
in T-75 cm2 flasks, with medium renewal performed every 
3–4 days. Subculturing of cells was done when the culture 
reached 80%–90% confluence.
Cell cytotoxicity and viability assay
For the evaluation of cytotoxicity, the lactose dehydrogenase 
(LDH) release assay was used. Briefly, Caco-2 cells were 
seeded in 96-well plates at a density of 1.33 × 104 cells/well 
and incubated for 21 days under the same culture conditions as 
described in the previous section. After 21 days, the medium 
was aspirated and replaced with serum-supplemented medium 
containing serial dilutions of the three CNMs.   Triton-X at 
0.05% was used as the control for maximum LDH release. 
The cells were exposed to the CNMs for 24 hours at 37°C, 
after which the culture medium was collected for LDH detec-
tion using Cytotox-One   Homogenous Membrane Integrity 
Assay Kit (Promega Corporation,   Madison, WI) following 
manufacturer’s instructions. Fluorescence was measured 
using a Tecan SpectraFluor Plus plate reader (Tecan Group 
Ltd, Mannedorf, Switzerland) with excitation wavelength of 
560 nm and emission wavelength of 590 nm. Cytotoxicity 
was calculated as follows:
  Cytotoxicity
FF
FF
test background
tritonX background
(%) =
−
−
×
-
100% %
where Ftest, Ftriton-X, and Fbackground represent the fluorescence 
readings from the test condition (CNM or vehicle alone), 
triton-X 0.05%, and background.
For the cell viability assay, treatment groups and condi-
tions were similar to those for the LDH release assay, except 
that 3-(4,5-dimethyliazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) was added to each well after medium removal 
and phosphate buffered saline (PBS) rinsing to remove resid-
ual CNM. Following 4 hours of incubation at 37°C, the well 
content was aspirated and 150 µL dimethylsulfoxide (DMSO) 
was added to dissolve formazan crystals.   Absorbance at 
570 nm was measured with a Tecan   SpectraFluorPlus reader. 
Cell viability was calculated as follows:
Viability
AbsA bs
AbsA bs
test background
vehicle control bac
(%) =
−
− k kground
× 100%
where Abstest, Absbackground, Absvehicle control represent the absor-
bance readings from the CNM-treated wells, the medium-
only wells, and the vehicle control wells, respectively.
Transepithelial electrical resistance 
(Teer) measurement in Caco-2 cells
Cells were seeded at a density of 1.2 × 104 cells/well in 
collagen-coated filter membrane polycarbonate transwell 
inserts (12 mm, 1 µm pore size, 0.3 cm2 growth area) obtained 
from BD Biocoat (Erembodegem, Belgium) and incubated at 
37°C for 21 days under the same culture conditions described 
in the previous section. The volumes of media were 0.2 mL 
and 0.5 mL on the apical and basolateral side, respectively. 
On day 21, the baseline transepithelial electrical resistance 
(TEER) values of Caco-2 cells were measured using Millicell 
ERS-2 Epithelial Volt-Ohm Meter to ensure cell monolayer 
integrity. Inserts that records .600 Ωcm2, which indicated 
good monolayer integrity, were subjected to experimentation. 
Media in both sides of the chambers were aspirated, and the 
chamber was washed twice with HBSS. The Caco-2 cells in 
the inserts were exposed to either HBSS buffer or CNM at 
1 mg/mL in HBSS for 24 hours at 37°C. The TEER values 
of these cells after treatment were recorded. Percent change 
in TEER after CNM exposure was calculated as follows:
  TEER
RR
RR
test background
vehicle control background
(%) % =
−
−
× 100
where Rtest, Rbackground, Rvehicle control represent the TEER readings 
from the CNM-treated wells, the no-cell control wells, and 
the vehicle control wells, respectively.
Transport of Lucifer Yellow (LY)  
across Caco-2 monolayer
Similar to the conditions for TEER measurements, 
Caco-2 cells were grown in the transwell inserts for 21 days 
before experimentation. The cells were treated with either 
HBSS buffer or 1 mg/mL of the CNM for 24 hours. At the 
end of CNM exposure, cells were washed three times with 
HBSS. Lucifer Yellow (100 µM in HBSS) was added to the 
apical chamber at a level of 200 µL, and 500 µL HBSS was International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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added to the basolateral chamber. At 1, 2, 4, and 24 hours, 
250 µL of sample from the basolateral chamber was 
removed and replaced with the same volume of fresh HBSS 
buffer. Samples collected from the basolateral wells were 
then   quantified using Tecan SpectraFluorPlus reader with 
  excitation/emission wavelength of 430/540 nm.
Tight junction staining  
with anti-ZO-1 antibody
Caco-2 cells were seeded in 4-well Lab-tek chamber 
glass slides from Nalge Nunc Inc (Naperville, IL) at a 
  density of 7.2104 cells/well and cultured for 21 days before 
  experimentation. Cells were exposed to 500 µL HBSS 
(vehicle control), 0.05% triton-X, or 1 mg/mL CNM for 4 and 
24 hours at 37°C. After incubation, cells were washed three 
times with ice-cold PBS, and fixed with ice-cold methanol for 
10 minutes. Subsequently, cells were rinsed with ice-cold PBS 
and blocked with 1% BSA in PBS for 30 minutes. Primary 
antibody (purified mouse anti-human ZO-1 obtained from 
BD Transduction Laboratories, San Jose, CA) was added at 
2 µg/mL and incubated at room temperature for 1 hour. The 
wells were then washed three times with PBS, with 5 minutes 
incubation after each wash, before the incubation with the 
secondary antibody (anti-mouse alexa-fluor 568) at 4 µg/mL 
for 1 hour at room temperature. Finally, cells were washed 
three times with PBS before viewing under a Carl Zeiss 
fluorescence confocal microscope using 40× objective (Carl 
Zeiss, Jena, Germany).
rhodamine-123 accumulation  
in Caco-2 cells
Cells were grown in 24-well culture slides at a density of 
8 × 104 cells/well and incubated for 21 days before experi-
mentation. Cells were exposed to either serial dilutions of 
CNM or HBSS for 90 minutes at 37°C, and were washed 
twice with HBSS at the end of incubation. Rhodamine-123 
(R-123, at 5 µM) was subsequently added to the cells 
and incubated for 90 minutes at 37°C. Cyclosporin A, an 
established P-glycoprotein (P-gp) inhibitor, was used as a 
positive control. After incubation, cells were washed with 
PBS and lysed with 1% triton-X to release the intracellular 
R-123. After centrifuging at 13,000 rpm for 10 minutes to 
remove cell debris, cell lysates were transferred to a 96-well 
plate for measuring fluorescence intensity of R-123 using 
a Tecan SpectraFluorPlus reader with   excitation/emission 
wavelength of 485/530 nm. The amount of R-123 accumulated 
was normalized to the protein content of the cells determined 
using the Bio-Rad protein assay kit   (Bio-Rad, Hercules, CA) 
as described by the manufacturer’s instructions.
statistical analysis
Where appropriate, results were expressed as mean ± SEM of 
at least three independent experiments. Statistical significance 
was assessed using one-way ANOVA followed by Fisher’s least 
significant difference (LSD) test for multiple comparisons. 
A P value of ,0.05 was considered statistically significant. 
Statistical analyses were carried out using SPSS software 
(v 19.0; IBM, Armonk, NY).
Results
Characterization of the  
functionalized CNMs
The three functionalized CNMs were used as received 
without further purification steps. Table 1 summarizes the 
characteristics of the three functionalized CNMs. Parameters 
including diameter, bundle dimension for the f SWCNTs, and 
carbonaceous purity were provided by the supplier. Common 
metal impurities, including cobalt, nickel, and iron, which are 
important in inducing toxicity to cells, were determined by 
ICP-OES. In general, the three metals were present in ,1% by 
weight in the three CNM   products. Figure 1 shows the SEM 
images of the CNM powder as received and the TEM images 
of the CNMs dispersed in HBSS. From these images, the 
three CNMs were in an aggregated state although they have 
been functionalized with hydrophilic groups to achieve better 
dispersibility than the non-functionalized, pristine forms.
Table1 Characterization of the functionalized carbon-based nanomaterials
OH-fullerenes f SWCNT-COOH f SWCNT-PEG
Diameter (nm)a 0.7 1.4 ± 0.1 1.4 ± 0.1
Bundle dimension NA 4–5 nm × 0.5–1.5 µm 4–5 nm × 0.5–0.6 µm
Co/Ni/Fe content (wt%)b Und/Und/0.39% Und/0.36%/0.19% Und/0.26%/0.21%
Carbonaceous purity ND .90% .80%
Notes: aParameters including diameter, bundle dimension and carbonaceous purity were provided by the source supplier (sigma-Aldrich, st Louis, MO); bas determined by 
elemental analysis (Dual-view Optima 5300 DV ICP-Oes system). 
Abbreviations:  NA,  not  applicable;  ND,  no  data;  Und,  undetected;  Oh-fullerenes,  polyhydroxylated  fullerenes;  f sWCNT-COOh,  single-walled  carbon  nanotubes 
functionalized with carboxylic acid; f sWCNT-Peg, single-walled carbon nanotubes functionalized with polyethylene glycol.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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the toxicity of Caco-2 cells exposed to OH-fullerenes, 
f SWCNT-COOH, and f SWCNT-PEG for 24 hours was 
minimal over the concentration range of 15.6–1000 µg/mL, 
and no significant difference was observed when the cytotox-
icity of the three CNM groups was compared to the vehicle 
control (P . 0.05).
The MTT assay which measures the mitochondrial 
activity in living cells is an established and popular assay to 
determine cytotoxicity. Of note, the reliability of the MTT 
assay in determining the cytotoxicity of non-functionalized, 
pristine SWCNT has been scrutinized;26,27 yet studies evalu-
ating potential interference from functionalized CNMs in 
MTT assays are lacking. In view of the limited data available, 
the MTT assay was performed on the Caco-2 cells treated 
with the CNMs, in a way similar to the LDH release assay, 
in the concentration range of 15.6–1000 µg/mL. Our results 
indicated that all three functionalized CNMs tested up to the 
highest concentration of 1000 µg/mL, did not significantly 
reduce the viability of Caco-2 cells as compared to vehicle 
control (Supplementary Figure 1). This finding corroborates 
with the LDH release assay that the three CNMs did not 
induce significant damage or cytotoxicity in Caco-2 cells.
As exposure of 24 hours may not be sufficient to demon-
strate that the CNMs are safe to cells, further studies involving 
longer exposure time were conducted using the LDH release 
assay (Supplementary Figure 2). After 72 hours of exposure, 
OH-fullerenes and f SWCNT-COOH did not have increased 
cytotoxicity, but a slight increase in the cytotoxicity of 
f SWCNT-PEG from 10% (24 hours treatment) to 30%–35% 
(72 hours treatment) was observed, which is somewhat surpris-
ing given that PEG functionalization of CNM yields derivatives 
of lower toxicity. Further investigation comparing the intracel-
lular fate of these functionalized CNMs in Caco-2 cells would 
shed light on the differential cytotoxicity upon longer exposure 
to the CNMs. However, compared to other well-accepted 
PEG-derivatized modulators such as Pluronic-P85 and vitamin 
E-TPGS 1000, the LDH release induced by f SWCNT-PEG 
is comparable. This is based on published reports that used 
Caco-2 cells as the model with cytotoxicity measured by 
LDH release,28,29 and showed that the cytotoxicity of 1 mg/mL 
vitamin E-TPGS 1000 or Pluronic-P85 was 30%–40% upon 
an exposure time of 1.5 and 4 hours, respectively.
After evaluating the cytotoxic potential of the functional-
ized CNMs in Caco-2 cells, it is of interest to examine if these 
novel materials could modulate the Caco-2 intestinal barrier 
function, from which insights into the potential of these 
CNMs as oral delivery vehicles could be obtained.   Barriers 
to oral drug delivery include primarily the presence of tight 
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Figure 1 seM and TeM of Oh-fullerenes, f sWCNT-COOh, and f sWCNT-Peg.
Abbreviations:  seM,  scanning  electron  microscopy;  TeM,  transmission  electron 
microscopy; Oh-fullerenes, polyhydroxylated fullerenes; fsWCNT-COOh, carboxylic 
acid  functionalized  single-walled  carbon  nanotubes;  fsWCNT-Peg,  poly(ethylene 
glycol) functionalized single-walled carbon nanotubes.
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Figure 2 Cytotoxicity of Oh-fullerenes (), f sWCNT-COOh (), and f sWCNT-
Peg () after 24 hours of treatment.
Abbreviations: LDh, lactose dehydrogenase; Oh-fullerenes, polyhydroxylated fullerenes; 
fsWCNT-COOh,  carboxylic  acid  functionalized  single-walled  carbon  nanotubes; 
fsWCNT-Peg, poly(ethylene glycol) functionalized single-walled carbon nanotubes.
Cytotoxicity of the functionalized  
CNMs in Caco-2 cell monolayer
The cytotoxicity of the three functionalized CNMs in 
Caco-2 cells was determined by the LDH release assay, 
which is an established cytotoxicity assay that probes plasma 
membrane integrity. To determine whether the functional-
ized CNMs could interfere with the assay, Caco-2 cells were 
lysed with 1% triton-X to yield cell lysate with which LDH 
activity was measured in the presence and absence of the 
CNMs. No significant difference in the generation of the 
fluorescent resorufin product was observed between these two 
testing conditions (data not shown). As shown in   Figure 2, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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junctions and the expression of drug efflux pumps in the 
intestinal epithelium. As such, subsequent evaluations were 
performed to probe the effects on tight junction integrity and 
drug efflux pump function as a result of CNM exposure.
Tight junction integrity of Caco-2  
cell monolayer after exposure  
to the functionalized CNMs
Disruption of the tight junctions in the intestinal epithelium 
would make drug transport via the paracellular route   possible. 
In this regard, tight junction integrity was examined by both 
morphological and functional properties, including the stain-
ing of ZO-1, a major tight junction-associated protein in 
Caco-2 cells,30,31 TEER measurements, and transport of LY 
which is a probe impermeable to Caco-2 monolayer when the 
tight junction is intact. Caco-2 cells were exposed to 1 mg/mL 
OH-fullerenes, f SWCNT-COOH, and f SWCNT-PEG for 
4 and 24 hours, and subsequently, ZO-1 was detected by 
immunofluorescence with confocal microscopy. As seen in 
Figure 3A, cells treated with vehicle control (HBSS) showed 
a strong, gasket-like and uniform distribution of ZO-1 
 ( Figure 3A),31 while cells treated with triton-X, which served 
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as the positive control, showed disrupted and abnormal 
localization of ZO-1 (Figure 3A). Of the three functionalized 
CNMs evaluated, only f SWCNT-COOH showed a weaken-
ing of ZO-1 immunofluorescence after 4 hours, which was 
further reduced after 24 hours (Figure 3A). Slight reduc-
tion in ZO-1 immunofluorescence could be noticed in cells 
treated with OH-fullerenes for 24 hours (Figure 3A). ZO-1 
immunofluorescence was largely unaffected upon exposure 
to f SWCNT-PEG for 24 hours (Figure 3A).
In addition to morphological examination, TEER measure-
ment was performed on Caco-2 cells treated with the three 
functionalized CNMs. A decrease in TEER reflects weakening 
of the tight junction that results in paracellular transport.32 
Differentiated Caco-2 monolayers grown in transwell inserts 
were exposed to 1 mg/mL of the three functionalized CNMs 
for 24 hours. As shown in Figure 3B, decreases in TEER 
could be observed when Caco-2 cells were exposed to the 
three CNMs; however, only the group treated with f SWCNT-
COOH was significantly lower compared to the control 
(P , 0.05). f SWCNT-PEG had the least effect on the TEER of 
Caco-2 cells. LY transport studies were carried out to further 
support our TEER observations. The positive control for this 
study included the cell-free insert and inserts with Caco-2 cells 
treated with triton-X, and both controls showed significantly 
higher LY transport across the monolayer throughout the study 
period (Figure 3C). Of note, LY was added to the transwell 
inserts after the monolayer was washed to remove residual 
CNM, to avoid LY binding to residual CNM that might poten-
tially confound the results. As early as 4 hours, Caco-2 cells 
treated with f SWCNT-COOH showed significantly higher LY 
transport, an observation that is in line with the ZO-1staining 
results (Figure 3A). At 24 hours, Caco-2 cells treated with 
OH-fullerenes and f SWCNT-COOH showed significantly 
higher LY transport compared to the control, and the extent 
of LY transport upon f SWCNT-COOH exposure was compa-
rable to that of cell-free control. f SWCNT-PEG exposure did 
not enhance LY transport over the study period of 24 hours. 
Taken together, the results from morphological and functional 
evaluation are in line, and f SWCNT-COOH appears to be 
the most promising among the three functionalized CNMs 
in modulating tight junctions.
It is of importance to determine whether the tight junc-
tion modulating effect by f SWCNT-COOH is reversible, 
as irreversibility would represent potential toxicity to the 
intestinal epithelium and f SWCNT-COOH may not be a 
good material for oral drug delivery. Therefore, time-course 
TEER measurements were carried out on Caco-2   monolayers 
exposed to f SWCNT-COOH and triton-X (as positive control) 
for 24 hours to examine if initial TEER reduction could be 
reversed over time. As shown in Figure 4, TEER was gradu-
ally increased over time after the removal of f SWCNT-COOH 
from the culture medium, and could return to approximately 
100% of initial value. In contrast, TEER of Caco-2 monolay-
ers treated with triton-X remained significantly lower than 
initial value over the 72-hour study period, indicating the 
irreversibility of triton-X treatment.   Collectively, the results 
presented in Figures 3 and 4 demonstrated the potential of 
f SWCNT-COOH in modulating the barrier function of intes-
tinal epithelium by reversibly disrupting tight junctions and 
promoting paracellular drug transport.
r-123 accumulation studies  
in Caco-2 cells
Another barrier to oral drug delivery is the presence of 
drug efflux pumps in the intestinal epithelium. It was thus 
of interest to determine whether the three functionalized 
CNMs could inhibit the P-gp efflux pump, thereby increasing 
P-gp drug substrate accumulation in Caco-2 cells. Various 
concentrations (1000, 500, 250, 125, 62.5 µg/mL) of the 
three functionalized CNMs were used to treat Caco-2 cells, 
and the cells were washed before the addition of the P-gp 
substrate R-123 to prevent any adsorption between CNMs 
and R-123. From Figure 5, a trend whereby an increase in 
R-123 accumulation in CNM-treated Caco-2 cells could be 
observed. Of note, f SWCNT-COOH at 500 and 1000 µg/mL 
and f SWCNT-PEG at 1000 µg/mL significantly increased 
R-123 accumulation by approximately 2.5-fold over control 
(P , 0.05), and the fold increase was higher as compared to 
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that oral dosing of CNMs is not toxic.16,19–21 Of importance, 
C60-  fullerenes and SWCNT, when administered at rela-
tively high doses of 2 g/kg and 1 g/kg, respectively, were 
excreted in feces 6 and 24 hours after oral administration, 
as demonstrated by the presence of compound-colored 
stool.16,21 Comparing with our results involving the recovery 
of TEER in the Caco-2 monolayer (Figure 4), the removal 
of f SWCNT-COOH after 24 hours of exposure in our 
experiment agreed well with the time frame of fecal excre-
tion of orally dosed SWCNT. Although a slight increase in 
cytotoxicity of f SWCNT-PEG was observed after 72 hours 
of exposure, the LDH release induced by f SWCNT-PEG 
treatment was comparable to other accepted PEG-based oral 
absorption modulators such as vitamin E-TPGS 1000 and 
Pluronic-P85.28,29 To support the application of CNMs in oral 
drug delivery, further studies could involve the determination 
of the amount of these CNMs that is absorbed orally and 
eliminated through fecal excretion. Compared to other in 
vitro studies that utilized Caco-2 cells for cytotoxicity evalu-
ation, our results are in line with those reported by Chiaretti 
et al in which no modification to Caco-2 cell growth was 
noted upon exposure to multi-walled carbon nanotubes.36 In 
contrast, Jos et al reported Caco-2 plasma membrane damage 
from f SWCNT-COOH exposure.37 This discrepancy is likely 
due to a much lower content (,1%) of metal contaminants in 
our functionalized CNMs samples as compared to that used 
by Jos et al of 5%–8%.37 The removal of metal contaminants, 
known to induce cellular oxidative stress, has been shown to 
mitigate the cytotoxic effect of carbon nanotubes.38
It is interesting to note that the differences in morpholo-
gies and surface modifications of the three functionalized 
CNMs evaluated in our study did not give rise to a difference 
in Caco-2 cytotoxicity upon short-term (24 hour) exposure 
but rather a differential in cytotoxicity upon long-term 
(72 hour) exposure and their ability to modulate the barrier 
function of Caco-2 cell monolayer. Of importance, the effect 
of f SWCNT-COOH on Caco-2 cells may be two-pronged: 
(1) increased paracellular drug transport via its reversible 
modulation on the tight junction, and (2) increased transport 
of P-gp substrates via inhibition of the P-gp efflux system. 
Such findings indicate considerable potential for f SWCNT-
COOH as an oral drug delivery system. The selective effect 
of f SWCNT-PEG on Caco-2 cells, whereby only P-gp efflux 
activity was inhibited without modulating tight junctions, 
would create unique opportunities for drug-specific oral 
delivery applications. Future studies involving the tracking 
of the intracellular fate of these novel CNMs would shed 
light on their differential biological properties.
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carboxylic acid functionalized single-walled carbon nanotubes; fsWCNT-Peg, poly(ethylene 
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the established P-gp inhibitor, cyclosporine A. Accumulation 
of the non P-gp substrate, rhodamine 110,33 in the presence of 
the three functionalized CNMs was not significantly different 
from that of vehicle control (data not shown). These results 
demonstrate that f SWCNT-COOH and f SWCNT-PEG have 
the ability to modulate P-gp efflux activity specifically, thus 
suggesting the potential in increasing oral bioavailability of 
P-gp drug substrates.
Discussion
Carbon nanomaterials have been extensively evaluated for 
biomedical applications such as drug delivery, with numerous 
proof-of-concept studies.3,4,7–9,14,15 However, very limited data 
are available to demonstrate their potential in oral drug deliv-
ery, partly because of the concern about the “fiber toxicities” 
of carbon nanotubes which are similar to those of asbestos.34 
Animal toxicological studies involving oral dosing of CNMs, 
counting both functionalized and non-functionalized forms, 
are very limited. From the available studies, all except the one 
by Folkman et al35 reported minimal toxicity from oral dosing, 
as assessed by various endpoints including death, behavioral 
changes, genetic damages, embryo-fetal development, and 
maternal toxicity.16,19–21 In light of these previous findings, 
we were interested in characterizing the effect of these novel 
materials on the function of the intestinal epithelium and 
examining the potential of these CNMs in oral drug delivery 
applications, which has not been reported before.
Our results showed minimal cytotoxicity to Caco-2 mono-
layer upon 24-hour exposure to the functionalized CNMs, 
and are in line with the animal studies reported by others International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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In summary, our current findings support the role of func-
tionalized CNMs in drug delivery applications, and potentially 
open up doors to the delivery of a variety of drug molecules 
which may not be limited to those for cancer, infections, and 
neurodegenerative diseases that CNMs have been applied to 
as drug delivery systems. The challenges ahead in translat-
ing these novel materials into human applications include 
standardizing the methods for the production of these novel 
materials and for the characterization of their toxicological 
profiles. It is encouraging to note that various regulatory 
bodies such as US Food and Drug Administration are putting 
forward guidelines to help industry in the development of 
medical products that involve the use of nanotechnology.
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Figure S1 Viability of Oh-fullerenes (), f sWCNT-COOh (), and f sWCNT-
Peg () as determined by MTT assay 24 hours post-treatment.
Abbreviations:  Oh-fullerenes,  polyhydroxylated  fullerenes;  fsWCNT-COOh, 
carboxylic  acid  functionalized  single-walled  carbon  nanotubes;  fsWCNT-Peg, 
poly(ethylene glycol) functionalized single-walled carbon nanotubes; MTT, 3-(4,5-
dimethyliazol-2-yl)-2,5-diphenyltetrazolium bromide.
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Figure  S2  Cytotoxicity  of  Oh-fullerenes  (),  f sWCNT-COOh  (),  and 
f sWCNT-Peg () after 72 hours of treatment.
Abbreviations:  LDh,  lactose  dehydrogenase;  Oh-fullerenes,  polyhydroxylated 
fullerenes; f sWCNT-COOh, carboxylic acid functionalized single-walled carbon 
nanotubes; f sWCNT-Peg, poly(ethylene glycol) functionalized single-walled carbon 
nanotubes.
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